Share This

Public company info - Shandong Boan Biotechnology Co. Ltd.-H Shares , 06955.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Shandong Boan Biotechnology Co. Ltd.-H Shares, 06955.HK - Cash Flow 2022-12 2021-12 2020-12
Net Cash Flow from Operating Activities -201,841 -246,278 -506,720
Net Cash Flow from Return on Investments & Servicing of Finance -7,355 -2,650 -11,788
　Interest Received 5,692 8,949 31
　Interest Paid -13,047 -11,599 -11,819
　Dividend Received 0 0 0
　Dividend Paid 0 0 0
　Others 0 0 0
Taxes (Paid) / Refunded 0 0 0
Net Cash Flow from Investing Activities -106,376 -441,245 -18,818
　Additions to Fixed Assets -81,291 -107,729 -25,053
　Disposal of Fixed Assets 0 0 0
　Increase in Investments 0 0 0
　Decrease in Investments 0 0 0
　Net Cash Flow with Related Parties 0 1,233,043 1,025,274
　Others -25,085 -1,566,559 -1,019,039
Net Cash Flow before Financing Activities -315,572 -690,173 -537,326
Net Cash Flow from Financing Activities 12,920 1,223,328 539,052
　New Loans 52,979 0 0
　Loans Repayment -18,605 -9,426 -486,222
　Fixed Income/Debt Instruments 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0
　Equity Financing 189,156 0 0
　Net Cash Flow with Related Parties 0 1,233,043 1,025,274
　Others -210,610 -289 0
Increase(Decrease) in Cash & Cash Equivalents -302,652 533,155 1,726
Cash & Cash Equivalents at Beginning of Year 531,703 3,629 1,903
Net Cash Flow due to Change in Exchange Rate/Others 4,447 -5,081 0
Cash & Cash Equivalents at End of Year 233,498 531,703 3,629
Currency Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.